3 ml of semaglutide Ozempic 2 mg/3 (0.68 mg/mL) prefilled pen that delivers 0.25 mg or 0.5 mg per injection Images Troubling Findings in Study of

A personalized evaluation can help determine whether a SOTA Wellness consultation is the right next step for medication selection, dosing, monitoring and long-term weight management.

Resources for verifying your dose Never rely on a single source

In clinical trials, people who took Wegovy lost an average of 15% of their body weight in 68 weeks

Patients with a history of GERD or hiatal hernia should discuss these conditions with their healthcare provider before starting semaglutide, as they may require closer monitoring, though a definitive risk relationship has not been established through controlled studies

Tirzepatide is showing a similar impact but is not yet FDA approved for this indication